Overview

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The effects of the medication, memantine, on brain functions and the symptoms of Alzheimer's Disease will be tested
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Diego
Treatments:
Memantine